Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma

被引:0
作者
Biyuan Luo
Fang Ma
Hao Liu
Jixiong Hu
Le Rao
Chun Liu
Yongfang Jiang
Shuyu Kuangzeng
Xuan Lin
Chenyang Wang
Yiyu Lei
Zhongzhou Si
Guangshun Chen
Ning Zhou
Chengbai Liang
Fangqing Jiang
Fenge Liu
Weidong Dai
Wei Liu
Yawen Gao
Zhihong Li
Xi Li
Guangyu Zhou
Bingsi Li
Zhihong Zhang
Weiqi Nian
Lihua Luo
Xianling Liu
机构
[1] The Second XiangYa Hospital of Central South University,Department of Oncology
[2] Burning Rock Biotech,Department of General Surgery
[3] The Second XiangYa Hospital of Central South University,Department of Hepatopancreatobiliary Surgery, The Second Xiangya Hospital
[4] Central South University,Department of Infectious Disease, The Second Xiangya Hospital
[5] Central South University,Department of Oncology
[6] 331 Hospital of Zhuzhou,Center of Organ Transplantation
[7] The Second Xiangya Hospital of Central South University,Department of Hepatobiliary Surgery, Hunan Provincial Hospital
[8] Hunan Normal University,Department of Gastroenterology
[9] The Second Xiangya Hospital of Central South University,Department of Infectious Disease
[10] The First Hospital of Changsha,Department of Orthopedics, The Second Xiangya Hospital
[11] Central South University,Hunan Key Laboratory of Tumor Models and Individualized Medicine
[12] The Second Xiangya Hospital,Department of Oncology, Central Hospital of Enshi Autonomous Prefecture
[13] Chongqing University Cancer Hospital,undefined
[14] Enshi Clinical College of Wuhan University,undefined
来源
BMC Medicine | / 20卷
关键词
DNA methylation; cfDNA; Hepatocellular carcinoma; Early detection of cancer; Liver cirrhosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 139 条
[1]  
Torre LA(2015)Global cancer statistics, 2012 CA: Cancer J Clin 65 87-108
[2]  
Bray F(2014)Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma Hepatology 59 1577-1590
[3]  
Siegel RL(2012)Fibrosis-dependent mechanisms of hepatocarcinogenesis Hepatology 56 769-775
[4]  
Ferlay J(2011)AASLD practice guideline: management of hepatocellular carcinoma: an update Hepatol (Baltimore, Md) 53 1020-1022
[5]  
Lortet-Tieulent J(2009)Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma Gastroenterology 137 110-118
[6]  
Jemal A(2011)Management of hepatocellular carcinoma: an update Hepatology 53 1020-1022
[7]  
Fuchs BC(2011)CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis Clin Gastroenterol Hepatol 9 161-167
[8]  
Hoshida Y(2015)Biomarkers for the early diagnosis of hepatocellular carcinoma World J Gastroenterol 37 10573-10583
[9]  
Fujii T(2002)Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease Hepatology 35 1431-1440
[10]  
Wei L(2016)CK19 and glypican 3 expression profiling in the prognostic indication for patients with HCC after surgical resection Plos ONE 11 e0151501-1403